Literature DB >> 23549962

Effects of gastrogastric fistula repair on weight loss and gut hormone levels.

Ciaran S O'Brien1, Gary Wang, James McGinty, Keesandra K Agénor, Roxanne Dutia, Antonia Colarusso, Koji Park, Ninan Koshy, Blandine Laferrère.   

Abstract

BACKGROUND: Weight regain after gastric bypass (GBP) can be associated with a gastrogastric fistula (GGF), in which a channel forms between the gastric pouch and gastric remnant, allowing nutrients to pass through the "old route" rather than bypassing the duodenum. To further understand the mechanisms by which GGF may lead to weight regain, we investigated gut hormone levels in GBP patients with a GGF, before and after repair.
MATERIALS AND METHODS: Seven post-GBP subjects diagnosed with GGF were studied before and 4 months after GGF repair. Another cohort of 22 GBP control subjects without GGF complication were studied before and 1 year post-GBP. All subjects underwent a 50-g oral glucose tolerance test and blood was collected from 0-120 min for glucose, insulin, ghrelin, PYY3-36, GIP, and GLP-1 levels.
RESULTS: Four months after GGF repair subjects lost 6.0 ± 3.9 kg and had significantly increased postprandial PYY3-36 levels. After GGF repair, fasting and postprandial ghrelin levels decreased and were strongly correlated with weight loss. The insulin response to glucose also tended to be increased after GGF repair, however no concomitant increase in GLP-1 was observed. Compared to the post-GBP group, GLP-1 and PYY3-36 levels were significantly lower before GGF repair; however, after GGF repair, PYY3-36 levels were no longer lower than the post-GBP group.
CONCLUSIONS: These data utilize the GGF model to highlight the possible role of duodenal shunting as a mechanism of sustained weight loss after GBP, and lend support to the potential link between blunted satiety peptide release and weight regain.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23549962      PMCID: PMC3702644          DOI: 10.1007/s11695-013-0917-z

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  47 in total

1.  Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial.

Authors:  José Manuel Ramón; Silvia Salvans; Xenia Crous; Sonia Puig; Albert Goday; David Benaiges; Lourdes Trillo; Manuel Pera; Luis Grande
Journal:  J Gastrointest Surg       Date:  2012-03-09       Impact factor: 3.452

2.  Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner.

Authors:  Alex Escalona; Fernando Pimentel; Allan Sharp; Pablo Becerra; Milenko Slako; Dannae Turiel; Rodrigo Muñoz; Claudia Bambs; Sergio Guzmán; Luis Ibáñez; Keith Gersin
Journal:  Ann Surg       Date:  2012-06       Impact factor: 12.969

3.  Bariatric surgery versus intensive medical therapy in obese patients with diabetes.

Authors:  Philip R Schauer; Sangeeta R Kashyap; Kathy Wolski; Stacy A Brethauer; John P Kirwan; Claire E Pothier; Susan Thomas; Beth Abood; Steven E Nissen; Deepak L Bhatt
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

4.  Analysis of glucagon-like peptide 1; what to measure?

Authors:  Annemieke C Heijboer; Anneke Frans; Marie Lomecky; Marinus A Blankenstein
Journal:  Clin Chim Acta       Date:  2011-03-15       Impact factor: 3.786

5.  Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery.

Authors:  Erik N Hansen; Robyn A Tamboli; James M Isbell; Jabbar Saliba; Julia P Dunn; Pamela A Marks-Shulman; Naji N Abumrad
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-03       Impact factor: 4.052

6.  GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)?

Authors:  Moahad S Dar; William H Chapman; John R Pender; Almond J Drake; Kevin O'Brien; Robert J Tanenberg; G Lynis Dohm; Walter J Pories
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

7.  Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats.

Authors:  Adam P Chambers; Lene Jessen; Karen K Ryan; Stephanie Sisley; Hilary E Wilson-Pérez; Margaret A Stefater; Shrawan G Gaitonde; Joyce E Sorrell; Mouhamadoul Toure; Jose Berger; David A D'Alessio; Stephen C Woods; Randy J Seeley; Darleen A Sandoval
Journal:  Gastroenterology       Date:  2011-07-12       Impact factor: 22.682

8.  Accelerated gastric emptying but no carbohydrate malabsorption 1 year after gastric bypass surgery (GBP).

Authors:  Gary Wang; Keesandra Agenor; Justine Pizot; Donald P Kotler; Yaniv Harel; Bart J Van Der Schueren; Iliana Quercia; James McGinty; Blandine Laferrère
Journal:  Obes Surg       Date:  2012-08       Impact factor: 4.129

9.  Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial.

Authors:  Ralph Peterli; Robert E Steinert; Bettina Woelnerhanssen; Thomas Peters; Caroline Christoffel-Courtin; Markus Gass; Beatrice Kern; Markus von Fluee; Christoph Beglinger
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

10.  Magnitude and variability of the glucagon-like peptide-1 response in patients with type 2 diabetes up to 2 years following gastric bypass surgery.

Authors:  Bart J Van der Schueren; Peter Homel; Mariam Alam; Keesandra Agenor; Gary Wang; David Reilly; Blandine Laferrère
Journal:  Diabetes Care       Date:  2011-11-28       Impact factor: 19.112

View more
  12 in total

1.  Endoscopic submucosal dissection with suturing for the treatment of weight regain after gastric bypass: outcomes and comparison with traditional transoral outlet reduction (with video).

Authors:  Pichamol Jirapinyo; Diogo T H de Moura; Christopher C Thompson
Journal:  Gastrointest Endosc       Date:  2020-01-31       Impact factor: 9.427

2.  Metabolic Effect of Foregut Exclusion Demonstrated by the Impact of Gastrogastric Fistula on Recurrence of Diabetes.

Authors:  Pichamol Jirapinyo; Andrew C Thompson; Paul T Kröner; Walter W Chan; Christopher C Thompson
Journal:  J Am Coll Surg       Date:  2017-12-22       Impact factor: 6.113

3.  No Effect on Change in Fasting Ghrelin at ≤ 12 Months and Increased at ≥ 24 Months After Roux-en-Y Gastric Bypass.

Authors:  Yong Wang; Jing Chen; Xiao-Ting Wu
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

Review 4.  Gastrogastric fistulae following gastric bypass surgery-clinical recognition and treatment.

Authors:  Eric M Pauli; Hiba Beshir; Abraham Mathew
Journal:  Curr Gastroenterol Rep       Date:  2014-09

Review 5.  A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy.

Authors:  Pichamol Jirapinyo; David X Jin; Taha Qazi; Nitin Mishra; Christopher C Thompson
Journal:  Obes Surg       Date:  2018-03       Impact factor: 4.129

6.  Effect of Gastrogastric Fistula Closure in Type 2 Diabetes.

Authors:  Katherine M Meister; Philip R Schauer; Stacy A Brethauer; Ali Aminian
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

7.  Five-year outcomes of transoral outlet reduction for the treatment of weight regain after Roux-en-Y gastric bypass.

Authors:  Pichamol Jirapinyo; Nitin Kumar; Mohd Amer AlSamman; Christopher C Thompson
Journal:  Gastrointest Endosc       Date:  2019-12-07       Impact factor: 9.427

Review 8.  Endoscopic Evaluation and Management of Late Complications After Bariatric Surgery: a Narrative Review.

Authors:  Vivek Kumbhari; Carel W le Roux; Ricardo V Cohen
Journal:  Obes Surg       Date:  2021-07-30       Impact factor: 4.129

9.  Surgical Management of Gastrogastric Fistula After Roux-en-Y Gastric Bypass: 10-Year Experience.

Authors:  Elias Chahine; Radwan Kassir; Mazen Dirani; Saadeddine Joumaa; Tarek Debs; Elie Chouillard
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

10.  Dose response for argon plasma coagulation in the treatment of weight regain after Roux-en-Y gastric bypass.

Authors:  Pichamol Jirapinyo; Diogo T H de Moura; William Y Dong; Galileu Farias; Christopher C Thompson
Journal:  Gastrointest Endosc       Date:  2020-01-03       Impact factor: 9.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.